Institut universitaire de cardiologie et de pneumologie de Québec, University Laval clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
- Minor: CELSIO · Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: RESSOURCE · General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound Trial sites expanded: 1 → 4 locations
- Notable: Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis Primary completion pushed from Oct 1, 2026 to Oct 1, 2027
- Notable: RECORDII · Systematic Ambulatory ECG Monitoring Following TAVI Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 4 | 1 |
Not charted: 11 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Heart Disease (4) · Lung Cancer (3) · Obesity (2) · NASH / MASH (1) · Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Institut universitaire de cardiologie et de pneumologie de Québec, University Laval's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.